MALT lymphoma risk factors: Difference between revisions

Jump to navigation Jump to search
 
(10 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{MALT lymphoma}}
{{MALT lymphoma}}
{{CMG}}{{AE}}{{SR}}
{{CMG}}{{AE}}{{SR}}, {{AY}}


==Overview==
==Overview==
The most potent risk factor in the development of gastric MALT lymphoma is [[helicobacter|''H.pyroli'' infection]]. About 5–10% of people with gastric MALT lymphoma do not have an ''H. pylori'' infection (''H. pylori'' negative). Other risk factors for gastric MALT lymphoma include [[Immunosuppressive drug|long-term immunosuppressant drug therapy]] and [[HIV infection]]. Common risk factors in the development of MALT lymphoma, in areas of the body other than the stomach, are [[autoimmune disorders]] such as [[Hashimoto's thyroiditis]], [[Sjogren’s syndrome]], and [[Celiac disease]].


==Risk Factors==
==Risk Factors==
*The most potent risk factor in the development of gastric MALT lymphoma is [[helicobacter|H.pyroli infection]].<ref name=riskfactorsmaltlymphoma1>Risks of Extranodal marginal zone of mucosa-associated lymphoid tissue (MALT lymphoma). Canadian Cancer Society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/malt-lymphoma/?region=on. Accessed on January 25, 2016</ref> Other risk factors include:<ref name=riskfactorsmaltlymphoma2>Risk factors of gastric lymphoma. Wikipedia 2016. https://en.wikipedia.org/wiki/Gastric_lymphoma. Accessed on January 25, 2016</ref>
*'''The most potent risk factor in the development of gastric MALT lymphoma is [[helicobacter|''H.pyroli'' infection]].'''
:*[[Immunosuppressive drug|Long-term immunosuppressant drug therapy]]
*About 5–10% of people with gastric MALT lymphoma do not have an ''H. pylori'' infection (''H. pylori'' negative). Other risk factors for gastric MALT lymphoma include:
:*[[HIV infection]]
**[[Immunosuppressive drug|Long-term immunosuppressant drug therapy]]
*Common risk factors in the development of MALT lymphoma in areas of the body other than the stomach are autoimmune disorders, such as:<ref name=riskfactorsmaltlymphoma1>Risks of Extranodal marginal zone of mucosa-associated lymphoid tissue (MALT lymphoma). Canadian Cancer Society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/malt-lymphoma/?region=on. Accessed on January 25, 2016</ref>
**[[HIV infection]]
:*[[Hashimoto's thyroiditis]]
:*[[Sjogren’s syndrome]]


*Common risk factors in the development of MALT lymphoma, in areas of the body other than the stomach, are [[autoimmune disorders]] such as:
**[[Hashimoto's thyroiditis]]
**[[Sjogren’s syndrome]]
**[[Celiac disease]]
==References==
==References==
{{reflist|2}}
{{reflist|2}}
Line 23: Line 26:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]

Latest revision as of 23:33, 29 January 2019

MALT lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating MALT Lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Upper GI Endoscopy

CT

MRI

Endoscopic Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

MALT lymphoma risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of MALT lymphoma risk factors

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onMALT lymphoma risk factors

CDC on MALT lymphoma risk factors

MALT lymphoma risk factors in the news

on MALT lymphoma risk factors

Directions to Hospitals Treating MALT lymphoma

Risk calculators and risk factors for MALT lymphoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2], Ahmed Younes M.B.B.CH [3]

Overview

The most potent risk factor in the development of gastric MALT lymphoma is H.pyroli infection. About 5–10% of people with gastric MALT lymphoma do not have an H. pylori infection (H. pylori negative). Other risk factors for gastric MALT lymphoma include long-term immunosuppressant drug therapy and HIV infection. Common risk factors in the development of MALT lymphoma, in areas of the body other than the stomach, are autoimmune disorders such as Hashimoto's thyroiditis, Sjogren’s syndrome, and Celiac disease.

Risk Factors

References

Template:WH Template:WS